AIFF vs YXT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AIFF exhibits severe financial distress despite strong revenue growth, as reflected in its Piotroski F-Score of 1/9 (indicating poor financial health) and the absence of an Altman Z-Score (implying no safety margin against bankruptcy). The company operates at a massive loss with negative ROE (-340.82%) and operating margin (-632.47%), while trading at an extreme valuation (Price/Sales of 49.92). Although revenue growth is explosive (1075.8% YoY), this is not sustainable without profitability. The stock's recent price surge is likely speculative, not fundamental.
YXT exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a critical liquidity shortage with a Current Ratio of 0.49. The company is plagued by deep negative profitability, including an ROE of -105.30% and a profit margin of -46.71%, while carrying a high Debt/Equity ratio of 2.28. Despite a very low Price/Sales ratio of 0.11, the lack of earnings and chronic long-term value destruction (-93.8% over 5 years) render the stock highly speculative. Recent short-term price spikes appear to be volatility-driven rather than fundamentally supported.
Compare Another Pair
Related Comparisons
AIFF vs YXT: Head-to-Head Comparison
This page compares Firefly Neuroscience, Inc. (AIFF) and YXT.COM Group Holding Limited (YXT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.